Pomalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 1 and 2 trialVaishali Sanchorawala, David C. Seldin, Anthony C Shelton et al.|Blood|2016Cited by 274
Neuralgic amyotrophy following high-dose melphalan and autologous peripheral blood stem cell transplantation for AL amyloidosisVina P. Nguyen, Vaishali Sanchorawala, Michelle Kaku et al.|Bone Marrow Transplantation|2017Cited by 5
Clinical utility of a novel non-invasive technology for monitoring severe neutropenia in anticancer therapy.Manuel Alva Bianchi, Branko Cuglievan, Toshiaki Iwase et al.|Journal of Clinical Oncology|2023Cited by 1
Defying the odds: 30 years in AL amyloidosis research—recent barriers to clinical trial enrollmentVaishali Sanchorawala, Andrew Staron, Natasha Burke et al.|Blood Advances|2024Cited by 1
Defying The Odds: A 30-Year Journey Through AL Amyloidosis Research With A Focus On Recent Structural/Clinical Barriers To Clinical Trial Enrollment PA154 (#212)Vaishali Sanchorawala, Andrew Staron, Bruna Barroso et al.|Unknown|2024Cited by 0